Anti-EG-VEGF antibody [EPR9699] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal EG-VEGF antibody. Carrier free. Suitable for WB, Flow Cyt (Intra) and reacts with Mouse, Human samples. Cited in 1 publication.
View Alternative Names
UNQ600/PRO1186, PROK1, Prokineticin-1, Endocrine-gland-derived vascular endothelial growth factor, Mambakine, EG-VEGF
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-EG-VEGF antibody [EPR9699] - BSA and Azide free (AB248951)
This data was developed using ab150375, the same antibody clone in a different buffer formulation.
Intracellular flow cytometric analysis of permeabilized NIH/3T3 cells labelling EG-VEGF with ab150375 at 1/10 dilution (red) or a Rabbit IgG (negative, green).
- WB
Unknown
Western blot - Anti-EG-VEGF antibody [EPR9699] - BSA and Azide free (AB248951)
This data was developed using ab150375, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-EG-VEGF antibody [EPR9699] (<a href='/en-us/products/primary-antibodies/eg-vegf-antibody-epr9699-ab150375'>ab150375</a>) at 1/1000 dilution
Lane 1:
Raw 264.7 cell lysate at 10 µg
Lane 2:
NIH/3T3 cell lysate at 10 µg
Lane 3:
ECV-304 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 12 kDa
false
Related conjugates and formulations (1)
-
Anti-EG-VEGF antibody [EPR9699]
Reactivity data
Product details
ab248951 is the carrier-free version of ab150375.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EG-VEGF plays a critical role in the formation and remodeling of blood vessels specific to endocrine glands. It is not part of a larger protein complex but operates through interaction with its receptor prokineticin receptor 1 (PROKR1). This unique interaction means that it has a specific ligand-receptor activity contributing to the regulation of vascular development especially in tissues undergoing hormonal changes. This makes EG-VEGF significant in contexts where localized and specific angiogenesis is essential.
Pathways
EG-VEGF is important in the regulation of angiogenesis and endothelial function. It fits into pathways that influence cell signaling associated with vascular development. One such pathway is the hypoxia-inducible factor (HIF) pathway which enhances the expression of EG-VEGF under low oxygen conditions. Another related protein is vascular endothelial growth factor (VEGF) whereby VEGF and EG-VEGF demonstrate distinctive yet occasionally overlapping functions in angiogenesis optimizing vascular growth within specific environments.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Journal of personalized medicine 12: PubMed35207643
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com